Direct Relief Accepts 2025 Seoul Peace Prize for Global Humanitarian Impact

May 05, 2025 10:30 PM IST | By 3BL
 Direct Relief Accepts 2025 Seoul Peace Prize for Global Humanitarian Impact
Image source: Kalkine Media

SEOUL, South Korea - On April 28, 2025, Direct Relief formally accepted the 2025 Seoul Peace Prize, one of the world’s most distinguished honors for humanitarian achievement, in recognition of the organization’s unwavering commitment to aiding people affected by poverty, disasters, and conflict.

“Peace is not just about the absence of conflict, but the presence of dignity, opportunity, and hope for all people,” said Dr. Byron Scott, Chief Executive Officer of Direct Relief, at the award ceremony today in Seoul. “This is what Direct Relief strives to create through our work—by ensuring everyone, regardless of where they live or their ability to pay, has access to the healthcare they need to live full and healthy lives.”

Established in 1990 to commemorate the Seoul Olympic Games, the Seoul Peace Prize recognizes individuals and organizations making significant global contributions to peace, development, and human welfare. Direct Relief, the 17th laureate, joins distinguished previous awardees such as Kofi Annan, Václav Havel, Ban Ki Moon, and Doctors Without Borders.

“It is with great sincerity that I extend my heartfelt congratulations to Direct Relief, an international medical relief organization, on being named laureate of the Seoul Peace Prize 2025, an award of deep and lasting significance,” said Jaeho Yeom, Chairman of the Seoul Peace Prize Cultural Foundation. “Direct Relief has exemplified true humanitarianism by providing medicines and medical supplies around the world—not through temporary aid, but sustained, patient-focused support uniquely tailored to each region. By maintaining the highest financial transparency and relying solely on private donations, Direct Relief maximizes the impact of giving, delivering medical assistance precisely where it’s most urgently needed.”

In presenting the prize, Christopher Koo, Chairman of the Seoul Peace Prize Selection Committee, underscored the urgency of Direct Relief’s work:

“The current global landscape, regrettably, continues to challenge our relentless efforts toward peace. In particular, countless victims of war and natural disasters are dying due to the lack of access to essential medicines and medical supplies. … Direct Relief was highly regarded for its unwavering commitment over the past 76 years to advancing peace through medical aid. The organization has quietly but powerfully carried out its mission to deliver healthcare where it is most needed.”

Since 2000, Direct Relief has delivered more than $16 billion in medical assistance to 136 countries and every U.S. state.

“This prize is a reminder that peace begins in the most fundamental way—in supporting the health and well-being of every person,” Dr. Scott concluded. “This is the peace we aim to foster every day.”

Click to continue reading highlights from Dr. Scott’s acceptance speech.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.